VOLITIONRX LTD 8-K

What Happened

• VolitionRx Limited announced its financial results and business updates for the quarter and fiscal year ended December 31, 2025 via a press release dated March 31, 2026. The company confirmed a conference call to discuss results on April 1, 2026 at 8:30 a.m. U.S. Eastern Time. The press release was furnished as Exhibit 99.1 to the Form 8-K.

Key Details

• Press release date: March 31, 2026 (Exhibit 99.1 furnished, not filed).
• Reporting period: quarter and fiscal year ended December 31, 2025.
• Conference call: April 1, 2026 at 8:30 a.m. Eastern Time to review results and updates.
• Filing note: Information was furnished under Form 8‑K General Instruction B.2 and is not deemed “filed” for purposes of Section 18 of the Exchange Act.

Why It Matters

• The company is communicating its latest earnings and business progress for Q4/FY2025; investors should review the March 31 press release and listen to the April 1 call for revenue, profit/loss, cash position, and operational updates that could affect the stock. The Form 8‑K’s “furnished” status means the press release is disclosed to investors but is not subject to the same Section 18 liabilities as a “filed” document.